Description Niquitin transparent anti-smoking patch 21 mg/24 h 7 units
Niquitin transdermal device 21 mg/24 h is a nicotine replacement drug that is indicated in the treatment of smoking cessation to manage the symptoms of nicotine withdrawal in patients wishing to stop smoking.
The active substance is nicotine.
Niquitin 21 mg/24 h (22 cm²) patches contain 114.00 mg of nicotine in each transdermal device. The other components are ethylene/vinyl acetate copolymer (40% AV). The occlusive backing consists of ethylene, vinyl acetate, polyethylene terephthalate, while the flow control membrane consists of a polyethylene film with polyisobutylene-based contact adhesive.
The removable protective layer is a siliconized polyester film.
Niquitin 21 mg/24 h is available in boxes of 7 or 28 transdermal devices.
Dosage of Niquitin 21 mg/24 h transdermal device
Niquitin 21 mg/24 h is intended for adults over 15 years of age. The dosage depends on the level of tobacco dependence, which can be assessed by the Fagerström test or by the number of cigarettes consumed per day.
Depending on how you feel, the dose can be increased in case of "withdrawal" or decreased in case of signs of overdose.
The treatment takes place in 3 periods, with an initial period of 3 to 4 weeks which aims to stop smoking. This is followed by a follow-up treatment in order to consolidate this cessation and to start nicotine withdrawal and end with therapeutic withdrawal. This last stage allows you to stop smoking.
All these 3 stages last 3 months but this duration can vary according to the individual response.
If the urge to smoke appears while taking Niquitin 21 mg/24 h, consult your doctor who will guide you towards the use of oral substitutes (Niquitin 2 mg gum or Niquitin 2 mg tablets).
Treatment with Niquitin 21 mg/24 h should not exceed 6 months.
Directions for use Niquitin transparent anti tobacco patch 21 mg/24 h 7 units
Mode of administration: The patches are used transdermally. After opening the sachet, the protective sheet of the transdermal device must be removed. The patch must be then applied directly to a clean and dry skin, without lesions (red, irritated, damaged skin) and where the skin presents little pilosity: trunk, upper part of the arm. To ensure perfect adhesion of the patch to the skin, press the patch with your palm for about 10 seconds.
Niquitin patches are best applied in the morning upon awakening and should remain in place for 24 hours and should not be cut off.
The area of application should be alternated each day, to avoid putting the device in the same place for a few days.
Before disposing of the device, it should be folded on itself, before disposing of it in a safe place.
Any used or unused device should be kept out of the reach of children and it is necessary to wash your hands after application.
If you need to go swimming, you can either remove the transdermal device and place it directly on its backing, so that it can be re-adhered to a well-dried skin. You can also cover the transdermal device with a waterproof adhesive bandage during the bath.
When showering, avoid directing the shower jet towards the device.
Duration of the treatment: Smoking cessation should be done as early as possible in the treatment, if after 9 months of treatment, this attempt to stop smoking completely has failed, it is recommended to take advice from a health professional to consider another strategy.
In case of overdose, symptoms include hypotension, weak and irregular pulse, respiratory distress, prostration, cardiovascular collapse and convulsions, and requires contacting a physician or emergency room.
Medical follow-up is necessary in cases of severe hepatic and/or renal insufficiency, evolving stomach or duodenal ulcer.
A risk of underdosing may occur during treatment, which is reflected by an urge to smoke, irritability, sleep disorders, agitation or impatience, or difficulty concentrating. The dosage of the medication will have to be modified. Also, signs of overdose such as nausea, abdominal pain, diarrhea, hypersalivation, sweating, headache, dizziness, decreased hearing or general weakness may occur.
Treatment with Niquitin patch should be stopped if skin irritation, itching, burning or severe reactions occur.
If in doubt or if you are taking other medications, ask your doctor or pharmacist for advice.
Quitting smoking during pregnancy is very important for you and your child. Quitting smoking during pregnancy requires medical advice and must be done under medical supervision by your doctor.
If you are breastfeeding and smoking, breastfeeding must be artificial. Taking the Niquitin 21 mg/ 24 h patch is not recommended during breastfeeding. You must refer to your doctor if you wish to stop smoking.
Français
English
